SOPHiA GENETICS SA
$5.19
▼
-0.98%
2026-04-21 09:33:00
www.sophiagenetics.com
NMS: SOPH
Explore SOPHiA GENETICS SA stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$371.96 M
Current Price
$5.19
52W High / Low
$5.7 / $2.58
Stock P/E
—
Book Value
$0.69
Dividend Yield
—
ROCE
-63.03%
ROE
-1.1%
Face Value
—
EPS
$-1.17
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
415
Beta
1.04
Debt / Equity
133.67
Current Ratio
1.96
Quick Ratio
1.84
Forward P/E
-8.39
Price / Sales
4.36
Enterprise Value
$329.57 M
EV / EBITDA
-4.76
EV / Revenue
4.26
Rating
Strong Buy
Target Price
$7.67
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | OptimizeRx Corporation | $7.2 | 26.21 | $134.53 M | — | 7.75% | 4.18% | $22.25 / $5.54 | $6.84 |
| 2. | TruBridge, Inc. | $23.18 | 77.96 | $339.43 M | — | 6.05% | 2.52% | $26.74 / $13.88 | $12.25 |
| 3. | So-Young International Inc. | $2.9 | — | $283.61 M | 0% | -4.01% | -13.61% | $6.28 / $0.74 | $2.25 |
| 4. | Carlsmed, Inc. | $10.94 | — | $293.52 M | — | -26.39% | -47.62% | $17.19 / $8.5 | $3.72 |
| 5. | Aclarion, Inc. | $3.55 | — | $7.74 M | — | -54.95% | -1.05% | $12.03 / $2.34 | $15.02 |
| 6. | GoodRx Holdings, Inc. | $2.37 | 26.67 | $811.9 M | — | 7.56% | 4.54% | $5.81 / $1.77 | $1.81 |
| 7. | National Research Corporation | $18.18 | 35.65 | $413.53 M | 3.52% | 22.99% | 51.24% | $22.79 / $9.76 | $0.62 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 21.71 M | 19.46 M | 18.32 M | 17.78 M | 17.73 M | — |
| Operating Profit | -18.52 M | -17.86 M | -18.49 M | -16.04 M | -17.44 M | — |
| Net Profit | -19.18 M | -20.02 M | -22.41 M | -17.39 M | -15.16 M | — |
| EPS in Rs | -0.27 | -0.28 | -0.31 | -0.24 | -0.21 | -0.28 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 77.27 M | 65.17 M | 62.37 M | 47.56 M |
| Operating Profit | -70.91 M | -66.57 M | -74.83 M | -87.82 M |
| Net Profit | -79 M | -62.49 M | -78.98 M | -87.45 M |
| EPS in Rs | -1.1 | -0.87 | -1.1 | -1.22 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 163.03 M | 155.31 M | 206.16 M | 243.84 M |
| Total Liabilities | 115.89 M | 58.82 M | 54.71 M | 43.71 M |
| Equity | 47.15 M | 96.49 M | 151.44 M | 200.13 M |
| Current Assets | 99.08 M | 99.41 M | 148.05 M | 196.25 M |
| Current Liabilities | 50.53 M | 26.8 M | 35.62 M | 26.81 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -35.89 M | -44.52 M | -53.22 M | -70.09 M |
| Investing CF | -8.67 M | -4.75 M | 12.97 M | 41.97 M |
| Financing CF | 30.18 M | 9.86 M | -2.82 M | -1.57 M |
| Free CF | -44.51 M | -52.69 M | -62.45 M | -80.47 M |
| Capex | -8.62 M | -8.18 M | -9.23 M | -10.38 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 18.56% | 4.49% | 31.14% | — |
| Earnings Growth % | -26.41% | 20.88% | 9.68% | — |
| Profit Margin % | -102.24% | -95.89% | -126.63% | -183.87% |
| Operating Margin % | -91.76% | -102.14% | -119.97% | -184.66% |
| Gross Margin % | 67.4% | 67.42% | 68.8% | 65.71% |
| EBITDA Margin % | -82.05% | -77.89% | -111.54% | -171.1% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.